New scalp elixir aims to thicken thinning hair
NCT ID NCT07271212
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a scalp elixir containing caffeine, panthenol, and growth factors on 60 healthy adults with hair thinning or baldness. Participants apply the product daily for 56 days, and researchers measure oil levels, hair density, thickness, length, and hair loss. The goal is to see if the elixir improves scalp and hair condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
caffeine, panthenol, insulin growth factor 1 (IGF-1), and fibroblast growth factor-7 (FGF-7) in a topical scalp elixir
What this could lead to
If it works, this could point toward a non-prescription scalp treatment to reduce hair thinning and improve hair density.
What could go wrong
This is a small, early-stage trial with only 60 participants and no blinding or placebo control for all groups. Results may not apply to everyone, and the effects may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAIR HEALTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hungkuang University
Taichung, 433304, Taiwan